NCT03483532View on ClinicalTrials.gov

Study of the Crystallization Inhibition Capacity of the Uric Acid in Urine in a Group of Lithiasic Patients After Intake of a Food Supplement

CompletedOBSERVATIONAL
Enrollment

54

Participants

Timeline

Start Date

September 6, 2017

Primary Completion Date

December 2, 2019

Study Completion Date

December 2, 2019

Conditions
Lithiasis
Interventions
DIETARY_SUPPLEMENT

Lit Control pH Up

dietary supplement based on citrate, saponins, magnesium, zinc and vitamin A

DIETARY_SUPPLEMENT

dry cocoa extract

(Theobroma cacao, fruit), 2 capsules of 750 mg per individual, dosed at a rate of one during the breakfast and another during dinner.

Trial Locations (1)

07500

Hospital de Manacor, Manacor

All Listed Sponsors
collaborator

Universidad de las Islas Baleares

UNKNOWN

lead

Devicare S.L.

INDUSTRY

NCT03483532 - Study of the Crystallization Inhibition Capacity of the Uric Acid in Urine in a Group of Lithiasic Patients After Intake of a Food Supplement | Biotech Hunter | Biotech Hunter